|
A SPECIAL
ANNOUNCEMENT FROM: |
|
 |
|
|
|
You're invited to our free, one-day seminar: Streamlining Drug Process Development. Register today!
|
 |
 |
|
Overcome drug formulation and manufacturing challenges |
When developing new drugs, shortening time-to-market, reducing waste of expensive APIs and minimizing overall development costs provide a distinct competitive advantage for pharmaceutical manufacturers. During this free one-day seminar, we will examine process and analytical improvements that can help shorten time from drug development to market. |
|
23 May - Cork, IE
8 June - Hemel Hempstead, UK
20 June - Breda, NL |
Agenda topics include: |
• Producing drug development systems from solubility enhancements to implants
• Understanding your formulation properties to define extruder parameters
• In-situ monitoring of the synthesis of your API molecules
• Incorporating twin-screw extruders into a continuous manufacturing process
• Deploying NIR in the extrusion process as a powerful tool for PAT
• Monitoring quality control of tablets and co-extrusions with imaging technologies |
|
Techniques covered: |
• Hot-melt extrusion and twin-screw granulation
• IR, Near-IR, NMR and Raman spectroscopy
• Rheology and multi-modal techniques |
|
Who should attend: |
• Research and formulation scientists engaged in oral dosage formulation, drug delivery
and implant development
• Process R&D scientists and manufacturing engineers looking to develop and scale-up
continuous manufacturing processes |
Register today › |
|
Registration opens at 9:00 am, and seminars begin at 9:30 am |
Date |
Location |
Seminar Time |
Tuesday
May 23, 2017 |
Tyndall National Institute
Cork, Ireland |
9:30 a.m. - 3:30 p.m. |
Thursday
June 8, 2017 |
Thermo Fisher Scientific
Hemel Hempstead, UK |
9:30 a.m. - 3:30 p.m. |
Tuesday
June 20, 2017 |
Thermo Fisher Scientific
Breda, Netherlands
|
9:30 a.m. - 3:30 p.m. |
|
Your privacy is important to us. View our Privacy Policy.
168 Third Avenue, Waltham, MA 02451 USA © 2017 Thermo Fisher Scientific Inc. All Rights Reserved. |
|
|
|
|
|
|